Sialodacryoadenitis virus (SDAV), a coronavirus of rats, evoked both serum neutralization and complement fixation antibody responses when inoculated intranasally in mice. Weanling gnotobiotic CD-1 mice inoculated intranasally with 1030 mean tissue culture infective doses of SDAV remained asymptomatic. Virus was recovered from the nasopharynx, trachea, and lung from day 2 to day 7. Viral antigen was readily detected by indirect immunofluorescence in the lung but rarely in the nasopharynx. Infected mice developed interstitial pneumonia. Susceptible mice contact exposed to experimentally infected mice developed antibody to SDAV. Epizootiological studies indicated that retired breeder mice can have complement-fixing antibody to SDAV and mouse hepatitis virus (MHV) in the absence of MHV infection. These studies show that SDAV is infectious for mice and can be a pathogen for the respiratory system. Thus, SDAV infection of mice may be responsible for spurious seroconversions to MHV.
Sialodacryoadenitis is a common, highly infectious, naturally occurring disease of rats that is characterized by self-limiting necrosis and inflammation of mixed or serous salivary glands, lacrimal glands, and upper respiratory mucous membranes (2). It is caused by a coronavirus, sialodacryoadenitis virus (SDAV), which is antigenically related to mouse hepatitis virus (MHV) (la). A second coronavirus of rats, Parker's rat coronavirus (PRCV) (3), also causes rhinitis and mild sialoadenitis and antigenically cross-reacts with SDAV and MHV (1, la, 3) .
Recently, during routine serological monitoring of rodent colonies at Yale, complement-fixing (CF) antibodies to MHV and SDAV were detected in sera of retired breeder ICR mice. The colony was asymptomatic, mice were free from lesions, and neither MHV nor SDAV was recovered from their tissues. Additional studies were performed to determine whether SDAV is infectious for mice and whether SDAV infection produces spurious seroconversions to MHV.
MATERIALS AND METHODS
Mice. Specific-pathogen-free CD-1, NIH Swiss, or NGP-N mice, 4 to 8 weeks old, were obtained from the breeding colony, Division of Aniinal Care, Yale University School of Medicine. They were housed in plastic boxes with autoclaved pine chip bedding and filter lids and were fed food and water ad libitum.
Axenic CD-1 male mice (6 to 8 weeks old; Charles River Breeding Laboratories, Wilmington, Mass.) were kept in a sterile, flexible-plastic isolator and were fed sterile food and water. Isolators were monitored repeatedly for bacterial and fungal contamination and remained sterile throughout the experiments.
Virus. Several SDAV strains were used for initial infectivity studies. The sources of these strains are given in Table 2 . Strain 721176, previously used for pathogenetic studies in rats (la), was used for the initial virus growth curve experiment in ICR mice and later for pathogenetic studies in axenic mice. This pool of SDAV was prepared from salivary glands of experimentally inoculated axenic rats as previously described (2). Virus titers were determined by inoculation of primary rat kidney cultures (1). The titer of the virus pool used for animal inoculation was 1050 mean tissue culture infective doses (TCID50).
For convenience, details of preliminary infectivity studies are given in Results.
Antibody determinations. Serum-neutralizing (SN) and CF antibodies to SDAV and CF antibody to MHV were assayed as described previously (la). Nonimmune serum and immune control sera of known titer were included in all tests.
Contact transmission. Thirty specific-pathogenfree mice were ear punched and inoculated intranasally (i.n.) with 1040 TCID50 of SDAV. Twenty-four hours later they were distributed randomly, six per box, among five boxes, each containing two to five uninfected mice. Filter lids were used on all boxes, and care was taken to avoid cross-contamination.
Three to four weeks postexposure, all mice were exsanguinated, and sera were tested individually for antibodies to SDAV.
Pathogenesis experiment. Forty axenic mice were inoculated i.n. with 103 TCID50 of SDAV, and virus quantitation of the inoculum was performed immediately. Mice were observed daily for clinical signs, and four mice were ra1idomly selected for necropsy each day for 10 days. They were anesthetized with sodium pentobarbitol and exsanguinated. Serum was stored at -20°C for antibody determination. The nasopharynx was irrigated with minimum essential medium in Hanks base containing 50% fetal bovine serum, 100 U of penicillin, and 100 mU of streptomycin per ml. Pieces of trachea, lung, salivary gland (submaxillary and parotid), and lacrimal gland (harderian and exorbital) were collected aseptically and stored at -60°C. Tissues and nasal washes were assayed for SDAV as previously described (2).
Sections of nasal turbinate, trachea, submaxillary and parotid salivary glands, and exorbital and harderian lacrimal glands were snap frozen on aluminum boats immersed in dry ice-alcohol baths. Lungs were inflated with 7.5% gelatin, held at 4°C for 1 h to gel, and then frozen on chucks at -20°C. Tissues were sectioned at 6,um, fixed in cold acetone for 16 h, and stained by indirect immunofluorescence techniques as previously described (2). Sections were examined with a Zeiss microscope fitted with an HB0200 Osram lamp, a BG-12 ultraviolet exciter filter, and no. 44 and 53 barrier filters.
Transverse sections of nasopharynx at three levels and sections of trachea, lung (inflated with fixative via the trachea), cervical lymph node, salivary glands, lacrimal glands, heart, thymus, liver, spleen, kidney, panc.eas, adrenal glands, gonad, eye, and brain were fixed in 10% neutral-buffered Formalin, sectioned at 6,m, stained with hematoxylin and eosin, and examined by light microscopy.
RESULTS
Antibody to SDAV in naturally and experimentally infected mice. CF antibodies to SDAV and MHV were detected in retired ICR breeder mice (Table 1 ). The pattern of seroconversion seemed atypical for MHV, since only several mice in each group had anti-MHV antibody.
In a separate experiment, antisera to SDAV were prepared by a single intraperitoneal or i.n. inoculation of NIH Swiss or NGP-N adult mice with various SDAV strains. By 3 to 4 weeks after inoculation, all groups of intraperitoneally inoculated mice had developed anti-SDAV CF and SN antibodies. Furthermore, all groups of i.n.-inoculated mice had SN antibody and five of eight had CF antibody to SDAV ( Table 2 ), indicating that active infection had occurred. This was confirmed in a preliminary infectivity trial. Adult ICR mice were inoculated i.n. with 1030 TCOD50 of SDAV strain 721176. Infectious virus was recovered from the lung by day 2, and titers gradually decreased to undetectable levels by day 8. Small quantities of virus were also recovered from the trachea (Fig. 1) .
In a second infectivity experiment, 30 ICR mice were divided into three groups of 10 mice each. One group was given 103.5 TCID50 of SDAV i.n., the second group was given two SDAY inoculations with a 2-week interval, and one group remained uninoculated. All mice were Contact transmission experiment. Contact transmission of SDAV, as determined by seroconversion, occurred in all boxes of mice, and the ratio of experimentally infected mice to contact-exposed mice per box had no apparent effect on the efficacy of transmission (Table 3) .
Pathogenesis. The pathogenesis of SDAV infection was characterized in axenic mice. Mice remained asymptomatic for 10 days after i.n. inoculation. SDAV was recovered from the trachea and lung by day 2 but was not detected in the respiratory tract after day 7 (Table 4) . Virus was not recovered from salivary or lacrimal glands.
Viral antigen was also restricted to the respiratory tract and was most readily detected in the lung. Multiple small groups of alveoli contained interstitial and lining cells with cytoplasmic fluorescence. There were also small amounts of fluorescing debris in some alveolar spaces. The nasal and tracheobronchial mucosa generally did not contain viral antigen. However, viral antigen was detected in a short segment of bronchial epithelium from one mouse on day 5 and in a segment of nasal epithelium from one mouse on day 5.
Macroscopic lesions were limited to multiple, discrete, red-brown foci distributed evenly over all lobes of the lung. Histologically, several foci of epithelial necrosis were found in the nasal mucosa of one mouse, but lesions were otherwise restricted to the lung. The typical pulmonary lesion was multifocal interstitial pneumonia ( Fig. 2 to 4) SDAV was recovered from both upper and lower respiratory tracts of experimentally infected mice, but lesions were detected primarily in the lower respiratory tract. Other tissues were unaffected. Thus, the tissue tropism of SDAV in mice was different than in experimentally infected rats, in which necrosis and inflammation of submaxillary, parotid, and harderian glands and upper respiratory mucosa is common and interstitial pneumonia does not occur (2).
Virus was not recovered from all inoculated axenic mice in the pathogenesis study, nor were the lesions seen in all mice. It is possible that all mice were not infected because they were not anesthetized for inoculation in the isolator. In addition, all infected mice may not have developed lesions or lesions may have been transient. Since SN antibodies were detected in sera of all mice by postinfection day 8, virus replication may have been below the detection level in some animals.
All SPF mice developed anti-SDAV SN antibody within 3 weeks after experimental infection, whereas only 62% developed CF antibodies. In rats, the SN antibody response after experimental SDAV infection appears earlier and is of higher magnitude than the CF antibody re- 
